Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I trial of topotecan TCS delayed until Q3 2004

Dec. 18, 2003

New findings on structure and function of prostate-specific membrane antigen

Dec. 17, 2003

Valera files Vantas NDA

Dec. 17, 2003

Independent committee recommends early end to phase III Velcade trial

Dec. 17, 2003

Japanese rights to bevacizumab and pertuzumab licensed to Chugai

Dec. 17, 2003

Targent acquires dibromodulcitol

Dec. 17, 2003

Novacea licenses North American rights to AQ4N

Dec. 17, 2003

Praecis collaborates with NCI on PPI-2458

Dec. 16, 2003

Avanir and Peregrine execute license agreement for antibody

Dec. 16, 2003

Phase I trial commences for CNTO-95

Dec. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...